FDA 483 - Bachem Americas, Inc. - June 03, 2019

An FDA inspection of Bachem Americas, Inc. in Torrance, CA, revealed a significant deficiency in their quality system. The firm failed to adequately determine the cause of out-of-specification (OOS) test results, specifically in three reviewed investigations related to materials used in commercial API manufacturing. This indicates a moderate severity issue concerning quality control and investigation processes.